Investors

Investor Overview

    

Corporate Profile

Synta Pharmaceuticals is an innovative, agile biopharmaceutical company focused on research, development and commercialization of novel oncology medicines that have the potential to change the lives of cancer patients. ... 

READ MORE

NASDAQ | SNTA (Common)
$0.38 (2.70%) + 0.01
Stock chart for: SNTA.O.  Currently trading at $0.38 with a 52 week high of $2.65 and a 52 week low of $0.15.
May 25, 2016 4:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.